Search

Journal articles A strategy for cardiovascular prevention: that’s what matters!

Author of the article: Michal Vrablík Source: Athero Review | 3/2019 16. 10. 2019

Journal articles Diabetes mellitus and heart failure: the role of SGLT2 inhibitors

Author of the article: Jindřich Špinar, Jiří Vítovec, Lenka Špinarová Source: Athero Review | 1/2018 7. 3. 2018

Journal articles Can we improve primary prevention of ischemic heart disease? Which way?

Author of the article: Ján Murín, Miroslav Pernický, Martin Wawruch Source: Athero Review | 3/2016 2. 11. 2016

Journal articles Role of microRNAs in the pathophysiology of atherosclerosis and their potential clinical use

Author of the article: Jan Novák, Miroslav Souček Source: Athero Review | 3/2016 2. 11. 2016

Journal articles ODYSSEY OUTCOMES Study: other clinical relevant analyses

Author of the article: Ján Murín Source: Athero Review | 2/2019 22. 8. 2019

Journal articles Challenging atherosclerosis, aggressiveness versus timing?

Author of the article: Jan Piťha Source: Athero Review | 1/2016 15. 2. 2016

Journal articles Thoracic Intradural Disc Herniation: Key Considerations in Operative Management

Author of the article: Charlotte Katharine Gunner, James Tomlinson, Anna Lillian Watts, Antony Rex Michael Source: Acta Rheumatologica | 1:1/2015 8. 12. 2015

Journal articles Dyslipoproteinemias in endocrinopathies

Author of the article: Zbynek Schroner Source: Athero Review | 2/2016 6. 6. 2016

Journal articles What other possibilities of reducing blood pressure we have, apart from antihypertensives

Author of the article: Miroslav Souček Source: Athero Review | 3/2016 2. 11. 2016

Journal articles Secondary dislipidemia in renal disease

Author of the article: Jan Vachek, MUDr. PhDr. Oskar Zakiyanov, PhD., Vladimír Tesař Source: Athero Review | 2/2016 6. 6. 2016

Journal articles Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors

Author of the article: Ján Murín Source: Athero Review | 3/2016 2. 11. 2016

Journal articles What is the most important for patients with familial hypercholesterolaemia?
MedPed project in the Czech and Slovak

Author of the article: Michal Vrablík, Katarína Rašlová, Tomáš Freiberger, Richard Češka Katarína Rašlová, Branislav Vohnout Source: Athero Review | 1/2016 15. 2. 2016

Journal articles Adverse metabolic effects of antihypertensive drugs. Is it clinically relevant at all?

Author of the article: Ondřej Petrák Source: Athero Review | 2/2016 6. 6. 2016

Journal articles Editorial board

Source: Athero Review | 2/2016 6. 6. 2016

Journal articles Peripheral arterial disease (PAD) of lower extremity and dyslipidemia

Author of the article: Denisa Čelovská, Viera Štvrtinová, Andrej Dukát Source: Athero Review | 3/2016 2. 11. 2016

Journal articles Familial hypercholesterolemia: clinical reports, molecular genetics and differential diagnosis

Author of the article: Michal Vrablík, Lucie Schwarzová, Tomáš Freiberger, Lukáš Tichý, Richard Češka Source: Athero Review | 1/2016 15. 2. 2016

Journal articles Statin-associated myopathy: clinical guideline of Slovak Atherosclerosis Association and Czech Society for Atherosclerosis

Author of the article: Daniel Pella, Anna Gvozdjáková, Ján Lietava, Jana Tisoňová, Katarína Rašlová, Branislav Vohnout (za Slovenskou Asociaci Aterosklerózy), Michal Vrablík, Vladimír Bláha, Renata Cífková, Richard Češka, Tomáš Freiberger, Pavel Kraml, Jan Piťha, Hana Rosolová, Vladimír Soška, Tomáš Štulc, Hana Vaverková, Zuzana Urbanová (za Českou Společnost Pro Aterosklerózu) Source: Athero Review | 1/2016 15. 2. 2016

Journal articles Diabetes mellitus and lipid metabolism

Author of the article: Viliam Mojto Source: Athero Review | 2/2016 6. 6. 2016

Journal articles High prevalence of cardiovascular risk factors and inadequate control of LDL cholesterol levels in the population of 40-year old men and 50-year old women in the Czech Republic

Author of the article: Zdeněk Chmelík, Michal Vrablík, Martina Vaclová, Věra Lánská Source: Athero Review | 3/2016 2. 11. 2016

Journal articles From dyslipidemia to ischemic heart disease and vice versa

Author of the article: Jan Piťha Source: Athero Review | 3/2016 2. 11. 2016

Journal articles Atherogenic dyslipidemia – a new target in cardiovascular prevention

Author of the article: Ľubomíra Fábryová Source: Athero Review | 3/2016 2. 11. 2016

Journal articles Turn in hypercholesterolemia treatment – PCSK9 inhibitors. What we know about the alirocumab (product Praluent^®) yet?

Author of the article: Richard Češka, Lucie Votavová, Tanja Aleksičová Source: Athero Review | 1/2016 15. 2. 2016

Journal articles Inertia – a possible reason for not reaching LDL-cholesterol targets: results of a multicenter observational study

Author of the article: Michal Vrablík, Ivana Šarkanová, Katarína Breciková, Petra Šedová, Martin Šatný, Aleš Tichopád Source: Athero Review | 2/2024 11. 11. 2024

Journal articles Alirocumab, Praluent^® in the light of studies

Author of the article: Richard Češka, Lucie Votavová Source: Athero Review | 2/2016 6. 6. 2016

Journal articles Arterin – a nutritional supplement in the treatment of dyslipidemia: results of a short-term clinical follow-up study